SS Innovations Names Sarah Romano as CFO to Drive Financial Strategy and FDA Pursuit

SS Innovations International has appointed Sarah Romano as CFO, leveraging her extensive medtech finance experience to support the company's global expansion and pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

SD Metrowire Staff
Healthcare
SS Innovations Names Sarah Romano as CFO to Drive Financial Strategy and FDA Pursuit

SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations. Her appointment comes at a pivotal time for SS Innovations, which is focused on making robotic surgery affordable and accessible globally.

SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

The appointment of Romano signals a strategic move to strengthen the company's financial foundation as it seeks to navigate the regulatory pathway for FDA approval. Her experience in raising capital and managing financial operations in the medtech space is expected to be instrumental in advancing the company's growth trajectory. For more details on the announcement, visit https://ibn.fm/pAqlP.

SS Innovations is committed to expanding its global presence, and with Romano's leadership, the company aims to optimize its financial operations to support its long-term objectives. The company's stock trades on NASDAQ under the ticker symbol SSII, and further updates are available in the company’s newsroom at https://ibn.fm/SSII.

Blockchain Registration

QR Code for Blockchain Registration